Clinical trial
Phase I Study of Alferon N Injection in Persons With Asymptomatic Human…
NCT00002078 · Purdue Frederick, Industry · Completed
Key facts
| NCT number | NCT00002078 |
|---|---|
| Title | Phase I Study of Alferon N Injection in Persons With Asymptomatic Human Immunodeficiency Virus (HIV) Infection |
| Official title | Phase I Study of Alferon N Injection in Persons With Asymptomatic Human Immunodeficiency Virus (HIV) Infection |
| Lead sponsor | Purdue Frederick, Industry |
| Collaborators | Walter Reed Army Institute of Research (WRAIR) U.S. Fed Henry M. Jackson Foundation for the Advancement of Military Medicine |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Interferon alfa-n3 |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: